Results 1 to 10 of about 9,025 (153)
Photochemotherapy for GvHD [PDF]
The International Journal of Artificial Organs, 2000 Irena Sniecinski
openalex +4 more sources
Frontiers in Immunology, 2021 Graft-vs. host disease (GVHD), both acute and chronic are among the chief non-relapse complications of allogeneic transplantation which still cause substantial morbidity and mortality despite significant advances in supportive care over the last few decades. The prevention of GVHD therefore remains critical to the success of allogeneic transplantation.
Joseph H. Antin, Mahasweta Gooptu
openaire +3 more sources
Analysis of Correlation between Body Mass Index and the Incidence of Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation [PDF]
Journal of Kerman University of Medical Sciences, 2021 Background: Graft-versus-host disease (GVHD) is a life-threatening complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Identifiying the probable risk factors can help the clinicians manage the consequences of GVHD.
Masoud Soleimani +6 more
doaj +1 more source
South Asian Journal of Cancer, 2022 Sanjeev Kumar Sharma Hematopoietic stem cell transplantation (HSCT) is the preferred treatment for high-risk and relapsed/refractory hematological malignancies.
Sanjeev Kumar Sharma +6 more
doaj +1 more source
Hematology, 2018 Abstract Acute graft-versus-host disease (GVHD) targets the crypts in the gastrointestinal (GI) tract that are responsible for the self-renewal of the intestinal mucosa. Recent advances in the identification and culture of intestinal stem cells have improved our understanding of the interactions between the microbiome and the immune ...
James L.M. Ferrara, Mohammed S. Chaudhry
openaire +5 more sources
The immunopathology of thymic GVHD [PDF]
Seminars in Immunopathology, 2008 The clinical success of allogeneic hematopoietic stem cell transplantation (HSCT) depends on the appropriate reconstitution of the host's immune system. While recovery of T-cell immunity may occur in transplant recipients via both thymus-dependent and thymus-independent pathways, the regeneration of a population of phenotypically naive T cells with a ...
Werner Krenger +3 more
openaire +4 more sources
Controversies and expectations for the prevention of GVHD: A biological and clinical perspective
Frontiers in Immunology, 2022 Severe acute and chronic graft versus host disease (GVHD) remains a major cause of morbidity and mortality after allogeneic hematopoietic cell transplantation.
Benjamin Watkins, Kirsten M. Williams
doaj +1 more source
Late-onset acute GVHD: clues for endothelial GVHD [PDF]
Blood, 2016 Late acute (LA) graft-versus-host disease (GVHD) has recently been added to the clinical spectrum of GVHD. In this issue of Blood, Holtan et al (and the Chronic GVHD Consortium) studied LA GVHD in a large prospective cohort and describe its link with circulating angiogenic factors ...
David Michonneau, Gérard Socié
openaire +3 more sources
Murine Models Provide New Insights Into Pathogenesis of Chronic Graft-Versus-Host Disease in Humans
Frontiers in Immunology, 2021 Allogeneic hematopoietic cell transplantation (allo-HCT) is a curative therapy for hematologic malignancies, but its success is complicated by graft-versus-host disease (GVHD). GVHD can be divided into acute and chronic types.
Qingxiao Song +8 more
doaj +1 more source
Oral Manifestations of Graft vs. Host Disease: A Comprehensive Review for Best Practice in Dentistry
Medicina, 2023 Graft-versus-host disease (GVHD) is a complication of hematopoietic stem cell transplantation (HSCT). GVHD may also develop following solid transplants or blood transfusions if white blood cells are transferred.
Michele Miranda +5 more
doaj +1 more source